Pharmacokinetic/pharmacodynamic (PK/PD) modeling and trial simulations to guide dose selection with CNTO 328, a chimeric anti-IL-6 monoclonal antibody (MAb), in patients with renal cell carcinoma (RCC)
| Autor: | H. Jang, U. Prabhakar, Q. Jiao, J. Ford, B. E. Miller, H. M. Davis, M. A. Graham |
|---|---|
| Rok vydání: | 2004 |
| Předmět: | |
| Zdroj: | Journal of Clinical Oncology. 22:2608-2608 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2004.22.90140.2608 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|